propranolol and Cholangiitis, Sclerosing studies

propranolol and Cholangiitis, Sclerosing

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

Excerpt	Relevance	Reference
"Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to cirrhosis and cholangiocellular carcinoma."	1.39	Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model. ( Demir, M; Dienes, HP; Goeser, T; Hunt, H; Mende, S; Nierhoff, D; Odenthal, M; Pryymachuck, G; Quasdorff, M; Schulte, S; Steffen, HM; Strack, I; Töx, U, 2013)
"Propranolol treatment of Mdr2(-/-) mice improved liver architecture."	1.37	β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis. ( Dienes, HP; Drebber, U; Odenthal, M; Schievenbusch, S; Schulte, S; Steffen, HM; Strack, I; Töx, U; Varnholt, H; Wendland, K, 2011)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Strack, I	2
Schulte, S	2
Varnholt, H	1
Schievenbusch, S	1
Töx, U	2
Wendland, K	1
Steffen, HM	2
Drebber, U	1
Dienes, HP	2
Odenthal, M	2
Mende, S	1
Hunt, H	1
Pryymachuck, G	1
Quasdorff, M	1
Demir, M	1
Nierhoff, D	1
Goeser, T	1

Studies

Strack, I

Schulte, S

Varnholt, H

Schievenbusch, S

Töx, U

Wendland, K

Steffen, HM

Drebber, U

Dienes, HP

Odenthal, M

Mende, S

Hunt, H

Pryymachuck, G

Quasdorff, M

Demir, M

Nierhoff, D

Goeser, T

Other Studies

2 other studies available for propranolol and Cholangiitis, Sclerosing

Article	Year
β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis. Laboratory investigation; a journal of technical methods and pathology, 2011, Volume: 91, Issue:2 Topics: Actins; Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Bin	2011
Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model. Digestive diseases and sciences, 2013, Volume: 58, Issue:5 Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cas	2013

Article

Year

β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.

Laboratory investigation; a journal of technical methods and pathology, 2011, Volume: 91, Issue:2

Topics: Actins; Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Bin

2011

Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.

Digestive diseases and sciences, 2013, Volume: 58, Issue:5

Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cas

2013